Despite substantial controversy (further discussed in Section 2.2), PSA and DRE are often used to screen for prostate cancer leading to millions of analyzed needle biopsies each year in the USA [21, 24, 25]. This evidence concerns the gene KLK3 and prostate carcinoma.